<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies of Epstein-Barr virus (EBV)-positive cell lines have identified several forms of virus latency, but the patterns of virus gene expression in EBV-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells appear more variable </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unclear to what extent these differences merely reflect the increased sensitivities of different detection methods </plain></SENT>
<SENT sid="2" pm="."><plain>Here, the design and validation of novel real-time RT-PCR assays to quantify relative levels of EBV transcripts are described </plain></SENT>
<SENT sid="3" pm="."><plain>When the new assays were used to screen a collection of endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, abundant Qp-driven EBNA1 expression was found, whereas the other latent transcripts (with the exception of LMP2A) were either absent or detectable only at trace levels </plain></SENT>
<SENT sid="4" pm="."><plain>Analysis of 12 nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> biopsies revealed significant levels of EBNA1 and LMP2A transcripts in almost every case but, in contrast to previous reports, LMP1 expression was undetectable </plain></SENT>
<SENT sid="5" pm="."><plain>These new quantitative assays may help to provide a clearer picture of EBV gene expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> material </plain></SENT>
</text></document>